A woman is igniting viral conversation after sharing that her sister is upset with the name she's chosen for her child — ...

Shares of Hims & Hers were on fire Monday because the FDA's new leader seems to be a fan of the company's business model.

Hims & Hers Health Inc. shares surged 24% to close at fresh record after Hunterbrook Media said the company is poised to be a ...

Hims & Hers achieved a 44% YoY increase in Q3 2024, surpassing 2 million active users. Find out what positions HIMS as a key ...

Should you invest $1,000 in Hims & Hers Health right now? Before you buy stock in Hims & Hers Health, consider this: The ...

Hims & Hers' financials are robust, with strong and accelerating revenue growth, growing free cash flow, manageable SBC, and ...

The United States duked out a rather tepid 0-0 game against England at Wembley in front of 78,346 fans. The U.S. women’s ...

Shares of Hims & Hers Health, Inc. (NYSE: HIMS) traded higher on Monday in response to President-elect Donald Trump's plans ...

Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions ...

Hims & Hers Health, Inc. (“Hims & Hers”) (NYSE: HIMS), the leading health and wellness platform, today announced Deb Autor, ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.